These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21324473)

  • 1. Vancomycin nephrotoxicity may be overstated.
    Moffett BS; Kim S; Edwards M
    J Pediatr; 2011 May; 158(5):865-6; author reply 866. PubMed ID: 21324473
    [No Abstract]   [Full Text] [Related]  

  • 2. Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity.
    Pritchard L; Baker C; Leggett J; Sehdev P; Brown A; Bayley KB
    Am J Med; 2010 Dec; 123(12):1143-9. PubMed ID: 21183005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children.
    McKamy S; Hernandez E; Jahng M; Moriwaki T; Deveikis A; Le J
    J Pediatr; 2011 Mar; 158(3):422-6. PubMed ID: 20888013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy.
    Ingram PR; Lye DC; Fisher DA; Goh WP; Tam VH
    Int J Antimicrob Agents; 2009 Dec; 34(6):570-4. PubMed ID: 19744837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin nephrotoxicity: myths and facts.
    Gupta A; Biyani M; Khaira A
    Neth J Med; 2011 Sep; 69(9):379-83. PubMed ID: 21978980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New target concentrations for vancomycin in Hong Kong.
    You JH; Chow SS; Lui JW; Ip M
    Int J Antimicrob Agents; 2011 Jan; 37(1):83-4. PubMed ID: 21074378
    [No Abstract]   [Full Text] [Related]  

  • 7. [Glycopeptides and the newborn infant's kidney].
    Fanos V; Benini D; Vinco S; Pizzini C; Khoory BJ
    Pediatr Med Chir; 1997; 19(4):259-62. PubMed ID: 9508651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin-induced nephrotoxicity.
    Gelfand MS; Cleveland KO
    Antimicrob Agents Chemother; 2013 May; 57(5):2435. PubMed ID: 23580581
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to "Vancomycin-induced nephrotoxicity".
    van Hal SJ; Paterson DL; Lodise TP
    Antimicrob Agents Chemother; 2013 May; 57(5):2436. PubMed ID: 23580582
    [No Abstract]   [Full Text] [Related]  

  • 10. Mild nephrotoxicity associated with vancomycin use.
    Downs NJ; Neihart RE; Dolezal JM; Hodges GR
    Arch Intern Med; 1989 Aug; 149(8):1777-81. PubMed ID: 2764651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of vancomycin-induced nephrotoxicity in the population with chronic kidney disease.
    Panwar B; Johnson VA; Patel M; Balkovetz DF
    Am J Med Sci; 2013 May; 345(5):396-9. PubMed ID: 23103440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy.
    Ingram PR; Lye DC; Tambyah PA; Goh WP; Tam VH; Fisher DA
    J Antimicrob Chemother; 2008 Jul; 62(1):168-71. PubMed ID: 18334494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editor's Spotlight/Take 5: Addition of Vancomycin to Cefazolin Prophylaxis Is Associated With Acute Kidney Injury After Primary Joint Arthroplasty.
    Wongworawat MD
    Clin Orthop Relat Res; 2015 Jul; 473(7):2193-6. PubMed ID: 25910778
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of humanized vancomycin infusion on kidney function and kidney injury in a translational rat model.
    Chang J; Pais GM; Jubrail R; Engel PL; Scheetz MH
    Int J Antimicrob Agents; 2024 May; 63(5):107118. PubMed ID: 38417707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin-associated nephrotoxicity: unintentional consequences of a loading dose?
    Flannery AH; Bachmeier H
    Crit Care Med; 2015 May; 43(5):e154. PubMed ID: 25876127
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factors for vancomycin nephrotoxicity: still a matter of debate*.
    Costa e Silva VT; Marçal LJ; Burdmann EA
    Crit Care Med; 2014 Dec; 42(12):2635-6. PubMed ID: 25402286
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.
    Lodise TP; Patel N; Lomaestro BM; Rodvold KA; Drusano GL
    Clin Infect Dis; 2009 Aug; 49(4):507-14. PubMed ID: 19586413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of nephrotoxicity with combination vancomycin-aminoglycoside antibiotic therapy.
    Pauly DJ; Musa DM; Lestico MR; Lindstrom MJ; Hetsko CM
    Pharmacotherapy; 1990; 10(6):378-82. PubMed ID: 2287556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of high permeability haemodialysis in acute renal failure due to vancomycin.
    Martín-Navarro JA; Petkov-Stoyanov V; Gutiérrez-Sánchez MJ
    Nefrologia; 2014; 34(5):688-90. PubMed ID: 25259829
    [No Abstract]   [Full Text] [Related]  

  • 20. [Contrast media and nephrotoxicity: a molecular conundrum].
    Andreucci M
    G Ital Nefrol; 2011; 28(4):355. PubMed ID: 21809301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.